Korea Drug Research Association Korea Drug Research Association

Korea Association of Research for API was established in 1994 under the aim to share knowledge and experience in the pharmaceutical ingredient area for the development of the applied technology and domestic pharmaceutical industry.
The members are composed of industry/academic/research community experts. Seminars and workshops are held for members for technical information exchanges and joint/government proposal, and technical information package publication are carried out for the technology development difficulty as its main business.

Korean Association of Research for Pharmaceutical Analysis shares knowledge and experiences in the pharmaceutical analysis to contribute to the pharmaceutical analysis science and apply technology development. We officially launched ourselves as part of the Research Association on June 12, 2008, to contribute to the domestic pharmaceutical industry development. The Korean Association of Research for Pharmaceutical Analysis (“Association of Research Analysis” below) is composed of approximately 1,400 analysts in over 330 pharmaceutical companies, CROs, government research institutes, and organized with the president, the vice president, a general affairs director, a finance director, an advertising executive, an expert adviser, an adviser, and the inspection organization. The Association of Research Analysis is a network in which concerns, knowledge, and experiences of the analysts are shared for the reliable analysis technique development and in which a home page for member information exchange and communication is operated. We regularly host expert workshops and seminars, carry out various education/training for professional workforce development, and promote to construct an efficient and reasonable analysis relation quality system as our main business.

As a plan to expedite global market advancement through securing of competitive research and development in the domestic pharmaceutical industry, the Herbal Medicine Research Association was launched on September 2011, with experts that have gathered goals to cope with the bottleneck phenomenon that is inhibiting the herbal medicine research and development and to strengthen the herbal medicine research and development activity. As our main business, we are drawing reasonable alternatives for the scientific standardization of the industry joint proposal on the herbal medicine research and development inhibiting factors, regulation rationalization on herbal medicines, government support expansion on herbal medicine research and development, and infrastructure construction of industry–academic cooperation. We continuously excavate new businesses regarding member opinions.

Korea Business Development Professional’s Group established and operated a group of pharmaceutical and bio-business development experts, including university TLO, research institutes and medical institutions TLO, venture and startup business development. Major projects include fostering global-level business development human resources, information exchange and discovery of promising business opportunities, discovery and development of promising startups, and efforts are being made to function as control towers in pharmaceutical and bio-business development.

Korean Society of Convergent Research on Microneedle Systems was established on August 30, 2023 as a research association under the association to contribute to the development of the pharmaceutical and bio-health industries by securing government communication channels to improve regulations on microneedle drug R&D and commercialization. It serves as a central organization for microneedle pharmaceutical experts in Korea, such as collecting opinions from industry, academia, research, and disease, and promoting microneedle manufacturing, quality, licensing regulations, guidelines, and exchanges between developers and pharmaceutical companies.